At 28, Sandra Dillon was diagnosed with myelofibrosis, a life-threatening blood disorder that can lead to acute leukemia. After participating in clinical trials and cutting edge treatments, Dillon has a deep appreciation for personalized medicine and genomics. Recorded on 09/15/2020. (#36357)